Julie Schneider to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Julie Schneider has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.181
-
Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
Score: 0.181